Four scientists from top pharmaceutical companies have collaborated to bring together the successful strategies for implementing an electronic patient reported outcome (ePRO) system in the form of an ebook. The handbook named "How to ...
Tags: ePRO Strategy, PHT
Posted in Cardiovascular by Qmed Staff on November 19, 2013 The Sapien 3 could be used in a broader range of patients than earlier TAVR products introduced internationally. Edwards Lifesciences (Irvine, CA) is in the news after The ...
Another member of the labiatae, or mint, family, thyme is an herb native to the Mediterranean basin and comes in many varieties. There is only one plant, thymus vulgaris, but the composition of the oil distilled from the plant shows ...
Cognoptix disclosed at the ‘Clinical Trials on Alzheimer’s Disease’ (CTAD) scientific meeting the strong results of a multi-site clinical trial of its SAPPHIRE II eye test, which is designed to identify Alzheimer’s ...
Tags: Cognoptix Eye, Alzheimer's Disease
Frutarom Switzerland Ltd., Health BU, joins forces with Aquanova AG, the German pharma GMP manufacturer of superior ingredient formulas, to market NovaSOL Curcumin, a solubilized, highly bioavailable form of curcumin for the dietary ...
Cartiva, a developer of products for the treatment of cartilage injuries and osteoarthritis, has signed an exclusive distribution agreement with Rehab Matrix Canada, a distributor of foot and ankle orthopedic medical devices. Pursuant to ...
Bayer has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD). AMD, a progressive eye disease that ...
Tags: Wet AMD Patients, Bayer
Boehringer Ingelheim has submitted European marketing authorization applications (MAA) to extend the indication to use tiotropium (Spiriva) Respimat for the treatment of asthma in adults aged 18 years and over. The MAA is based on results ...
Alphaeon, a wholly-owned subsidiary of Strathspey Crown Holdings, has acquired an exclusive US license from Schwind eye-tech solutions to market the AMARIS excimer laser system, for an undisclosed amount. The laser system, launched in ...
Tags: Alphaeon, Vision Correction
US-based CEL-SCI has obtained an approval from the Health Protection Administration, Ministry of Health, of the Croatian Republic to begin patient enrollment in Phase III clinical trial of its investigational cancer immunotherapy treatment, ...
Switzerland-based Helsinn group has granted Chugai Pharma Marketing, a wholly-owned subsidiary of Chugai Pharmaceutical, exclusive commercialization rights to their ghrelin receptor agonist, anamorelin, for the three major European pharma ...
Tags: Helsinn group, Pharma Marketing
A.P. Pharma, a specialty pharmaceutical company, has initiated a program to expand its pipeline of sustained release products, including a new program targeting the relief of post-surgical pain. The company also announced it will pursue a ...
Tags: A.P.Pharma, Pipeline Expansion
US-based AngioScore has presented six-month clinical and quantitative coronary angiography results from the first-in-human (FIH) clinical trial of its drug-coated AngioSculpt PTCA scoring balloon catheter at the Transcatheter Cardiovascular ...
Tags: AngioScore, Balloon Catheter
About 30 percent of heart attacks, strokes and deaths from heart disease can be prevented in people at high risk if they switch to a Mediterranean diet rich in olive oil, nuts, beans, fish, fruits ...
Tags: mediterranean, diet, health, heart disease
US-based TransCelerate BioPharma is launching three new global initiatives to further advance efficiency in clinical trials and accelerate the development of new medicines: creation of common clinical trial protocol templates, development ...
Tags: TransCelerate, clinical trial, Global Initiative, Cubist Pharmaceuticals